U.S. Markets open in 4 hrs 47 mins
  • S&P Futures

    3,630.25
    -2.50 (-0.07%)
     
  • Dow Futures

    29,953.00
    -45.00 (-0.15%)
     
  • Nasdaq Futures

    12,103.25
    +27.25 (+0.23%)
     
  • Russell 2000 Futures

    1,847.90
    -3.60 (-0.19%)
     
  • Crude Oil

    45.19
    +0.28 (+0.62%)
     
  • Gold

    1,809.50
    +4.90 (+0.27%)
     
  • Silver

    23.44
    +0.15 (+0.62%)
     
  • EUR/USD

    1.1901
    +0.0004 (+0.0357%)
     
  • 10-Yr Bond

    0.8820
    0.0000 (0.00%)
     
  • Vix

    21.79
    -0.87 (-3.84%)
     
  • GBP/USD

    1.3338
    -0.0021 (-0.1560%)
     
  • USD/JPY

    104.3810
    -0.0990 (-0.0948%)
     
  • BTC-USD

    19,068.67
    +214.68 (+1.14%)
     
  • CMC Crypto 200

    378.10
    +8.35 (+2.26%)
     
  • FTSE 100

    6,421.52
    -10.65 (-0.17%)
     
  • Nikkei 225

    26,296.86
    +131.27 (+0.50%)
     

NOTICE For Investors in Bayer Aktiengesellschaft: Over 10,000 Lawsuits in connection with Monsanto's Roundup announced by Shareholders Foundation

Newsfile Corp.
·2 min read

San Diego, California--(Newsfile Corp. - February 25, 2020) - The Shareholders Foundation, Inc. announced that over 10,000 lawsuits are pending in connection with Monsanto's Roundup.

Investors, who purchased shares of Bayer Aktiengesellschaft (OTC Pink: BAYRY) (OTC Pink: BAYZF) and continue to hold any of those Bayer shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The plaintiffs allege to have been exposed to glyphosate-based products manufactured by Bayer's subsidiary Monsanto. Glyphosate is the active ingredient contained in a number of Monsanto's herbicides, including Roundup-branded products. The plaintiffs allege personal injuries resulting from exposure to those products, including non-Hodgkin lymphoma (NHL) and multiple myeloma, and seek compensatory and punitive damages.

In August 2018, a state court jury in San Francisco, California, awarded roughly US$39 million in compensatory and US$250 million in punitive damages to a plaintiff who claimed that a Monsanto product caused his non-Hodgkin lymphoma. The punitive damages were subsequently reduced by the trial court to roughly US$39 million. Bayer has filed an appeal with the California Court of Appeal.

Those who purchased Bayer Aktiengesellschaft (OTC Pink: BAYRY) (OTC Pink: BAYZF) shares should contact the Shareholders Foundation, Inc.

CONTACT:

Shareholders Foundation, Inc.
Michael Daniels
+1 (858) 779-1554
mail@shareholdersfoundation.com
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108

The Shareholders Foundation, Inc. is a professional portfolio legal monitoring and a settlement claim filing service, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. The Shareholders Foundation, Inc. is not a law firm. Any referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is only provided as a public service. It is not intended as legal advice and should not be relied upon.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/52760